Following the US approval of the Agent paclitaxel-coated balloon for the treatment of in-stent restenosis (ISR), the first coronary procedures with the device were performed Tuesday morning at two ...

This study was conducted to develop new modified duplex velocity criteria to better define normal carotid (0-< 30%) versus abnormal (≥ 30%) carotid in-stent restenosis. Eighty-three patients who ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Consultant ...

Abbott has returned to the field of bio-absorbable, dissolving stents, and in somewhat uncharted territory. | Abbott has ...

First-of-its-kind, Esprit BTK Everolimus Eluting Resorbable Scaffold System is designed to keep treat chronic ...

New study findings underscore gaps in clinical trial representation of women and Hispanics for peripheral artery disease (PAD) and chronic limb-threatening ischemia (CLTI) research. All studies were ...

This includes studies for the treatment of femoral artery disease, coronary in-stent restenosis, and below-the-knee ...

For patients with end-stage kidney disease (ESKD), a high preoperative leukocyte glucose index (LGI) is associated with ...

These advancements promise to enhance patient outcomes by preventing restenosis, which is the re-narrowing of the coronary arteries—a common complication following angioplasty procedures. Innovation ...

PRNewswire Tampa Florida [US] April 20 Concept Medical a pioneer in innovative drug delivery technologies proudly announces ...

To the Editor: In their article on the LIFE-BTK trial, Varcoe et al. (Jan. 4 issue) 1 compare treatment with a drug-eluting scaffold with angioplasty in patients with infrapopliteal artery disease ...

There has been an ongoing debate regarding which duplex ultrasound (DUS) criteria to use to determine the rate of in-stent restenosis. This prospective study revisits DUS criteria for determining ...